NISHINO ET AL.
3
AcOEt (2 mL), MeOH (2 mL), and 1 N aqueous HCl was
added to the mixture at −78ꢀC and stirred for 1 hour at
room temperature. The reaction was basified with satu-
rated aqueous NaHCO3, and 0.17 g/mL of aqueous
Rochelle's salt at 0ꢀC was added to the mixture and
stirred for 1 hour at room temperature. The mixture was
extracted with AcOEt, and the organic layer was washed
with brine, dried over anhydrous Na2SO4, filtered, and
evaporated. The crude residue was purified by silica gel
column chromatography (AcOEt to AcOEt/MeOH =
20/1) to afford 7 (71 mg, 55%) as a yellow amorphous.
1H NMR (500 MHz, CDCl3) δ 9.70 (1H, s), 8.34 (1H,
d, J = 6.0 Hz), 8.31 (1H, s), 8.10 (1H, dd, J = 8.1, 1.4 Hz),
7.97 (1H, dd, J = 7.9, 1.7 Hz), 7.89 (1H, dd, J = 7.1, 1.5
Hz), 7.66–7.56 (3H, m), 6.72 (1H, d, J = 6.0 Hz), 2.67–2.61
(4H, m), 1.30–1.18 (2H, m), 1.15–1.03 (2H, m), 0.52 (6H,
t, J = 7.4 Hz). 13C NMR (100 MHz, CDCl3) δ192.4, 154.2,
152.3, 149.6, 136.1, 135.8, 134.6, 134.5, 130.2, 130.1, 129.2,
129.1, 127.2, 126.6, 125.6, 111.7, 52.3, 20.3, 11.2. IR (neat)
cm−1: 2962, 2872, 1683, 1580, 1495, 1460, 984, 832,
811, 774; HRMS (FAB, m/z): [M+H]+ calcd for
C22H25N2O, 333.1967; found, 333.1965.
124.6, 122.9, 108.2, 53.4, 19.9, 10.8. IR (neat) cm−1: 2961,
2926, 1640, 1514, 1462, 1359, 777; HRMS (FAB, m/z): [M
+H]+ calcd for C22H25N2O2, 349.1916; found, 349.1921.
2.2.3 | Optical resolution of 2
A solution of racemic 2 (1.0 mg) in CHCl3 (0.1 mL) was
applied for one injection to a preparative HPLC with chi-
ral stationary phase (column: CHIRALPAK ID, 10 mm ×
250
mm;
eluent:
hexane/EtOH/TFA/Et3N
=
85/15/0.5/0.1, flow rate: 0.7 mL/min, detection: 254 nm).
The separation was repeated 12 times. Collected fractions
for each enantiomer were concentrated in vacuo to give a
residue. The residue was dissolved with saturated aque-
ous NaHCO3 (2 mL) and neutralized to pH 7.0 by 1 N
aqueous HCl. The H2O layer was saturated by NaCl and
extracted with CH2Cl2 (20 mL × 10). The organic layer
was dried over Na2SO4, filtered, and evaporated to give a
residue. The residue was purified by reverse phase col-
umn chromatography on Sep-Pak C18 Plus Short Car-
tridge (H2O to MeOH) to give (+)-2 and (−)-2.
(−)-2 (first eluting enantiomer on HPLC analysis):
20
[α]D –241 (c = 0.8, EtOH, 93% ee), CD λext (EtOH) nm
2.2.2 | 8-[4-(Dipropylamino)pyridine-
3-yl]-1-naphthoic acid (2)
(Δε): 334 (4.02), 327 (1.65), 322 (4.83), 281 (–25.4),
244 (21.1), 220 (31.7). UV λmax (EtOH) nm (log ε):
292 (4.13), 227 (4.53).
2-Methyl-2-butene (425 μL, 4.0 mmol) and aqueous
NaClO2 [109 mg, 1.20 mmol in H2O (1 mL)] was added
to a solution of 7 (134 mg, 0.40 mmol) in CH3CN (2.0
mL) at room temperature. After the mixture was cooled
to 0ꢀC, 10% (v/v) H2SO4 (640 μL, 0.30 mmol) was added
to the reaction mixture and stirred for 3 hours at 0ꢀC.
The mixture was quenched with 5% (w/v) aqueous
NaHCO3 (6.0 mL), and then concentrated in vacuo. The
solution was diluted with MeOH and filtered to remove
inorganic salts. The filtrate was evaporated to give a resi-
due. The residue was dissolved with H2O (20 mL) and
neutralized to pH 7.0 by 1 N aqueous HCl and saturated
aqueous NaHCO3. The H2O layer was saturated by
adding NaCl, extracted with CH2Cl2 (20 mL × 10), dried
over Na2SO4, filtered, and evaporated to give a residue.
The crude residue was purified by preparative TLC
(CHCl3/MeOH/H2O = 10/1/0 to 65/35/5) to afford
2 (108 mg, 78%) as a colorless amorphous.
(+)-2 (second eluting enantiomer on HPLC analysis):
[α]D +247 (c = 1.1, EtOH, 87% ee), CD λext (EtOH) nm
(Δε): 334 (–2.02), 326 (–0.12), 322 (–2.75), 283 (27.2),
243 (–19.9), 220 (–27.8).
20
2.2.4 | Acylative kinetic resolution of
8 in the presence of (−)-2
Et3N (260 μL, 0.052 mmol) and (−)-2 (149 μL, 0.58 μmol)
was added to a solution of racemic 8 (10 mg, 0.058 mmol)
in toluene (160 μL). The mixture was stirred for
10 minutes at −20ꢀC. Then, (i-PrCO)2O (7.3 μL,
0.44 mmol) was added to the mixture and stirred for
53 hours at −20ꢀC. The reaction was quenched with
MeOH, and the reaction mixture was evaporated to give
a residue. The residue was purified by preparative TLC
(n-hexane/AcOEt = 5/1) to give 8 (Rf 0.1) and 9 (Rf 0.6).
The enantiomeric excesses of 8 and 9 were determined by
HPLC analysis with the chiral stationary phase.
HPLC conditions for 8: column: CHIRALCEL OD
(4.6 mm × 250 mm), eluent: n-hexane/i-PrOH = 90/10,
flow rate: 1.0 mL/min, detection: 254 nm, retention time:
tR = 11.1 min (S), 15.6 min (R).23
HPLC conditions for 9: column: CHIRALCEL OD-H
(4.6 mm x 250 mm), eluent: n-hexane/i-PrOH = 98/2,
1H NMR (500 MHz, CDCl3) δ 8.15–8.10 (1H, m), 7.89
(1H, d, J = 8.0 Hz), 7.84 (1H, s), 7.81 (1H, d, J = 8.4 Hz),
7.60 (1H, d, J = 6.0 Hz), 7.49 (1H, t, J = 8.0 Hz), 7.44 (1H,
t, J = 7.2 Hz), 7.19 (1H, d, J = 6.4 Hz), 6.61 (1H, d, J = 7.2
Hz), 3.25–3.14 (2H, m), 3.11–2.98 (2H, m), 1.60–1.43 (2H,
m), 1.37–1.18 (2H, m), 0.51 (6H, t, J = 7.6 Hz). 13C NMR
(75 MHz, CDCl3/CD3OD) δ176.5, 157.6, 141.2, 139.9,
137.9, 134.4, 133.5, 129.8, 129.1, 128.1, 127.5, 126.2, 125.7,